These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 11520455)

  • 1. Localization of the 3' IgH locus elements that effect long-distance regulation of class switch recombination.
    Pinaud E; Khamlichi AA; Le Morvan C; Drouet M; Nalesso V; Le Bert M; Cogné M
    Immunity; 2001 Aug; 15(2):187-99. PubMed ID: 11520455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic deletion of the whole IgH 3' regulatory region (hs3a, hs1,2, hs3b, and hs4) dramatically affects class switch recombination and Ig secretion to all isotypes.
    Vincent-Fabert C; Fiancette R; Pinaud E; Truffinet V; Cogné N; Cogné M; Denizot Y
    Blood; 2010 Sep; 116(11):1895-8. PubMed ID: 20538806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of a downstream boundary of the 3' IgH regulatory region.
    Manis JP; Michaelson JS; Birshtein BK; Alt FW
    Mol Immunol; 2003 Jan; 39(12):753-60. PubMed ID: 12531286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo redundant function of the 3' IgH regulatory element HS3b in the mouse.
    Bébin AG; Carrion C; Marquet M; Cogné N; Lecardeur S; Cogné M; Pinaud E
    J Immunol; 2010 Apr; 184(7):3710-7. PubMed ID: 20176739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of epsilon germline transcription and switch region mutations by IgH locus 3' enhancers in transgenic mice.
    Laurencikiene J; Tamosiunas V; Severinson E
    Blood; 2007 Jan; 109(1):159-67. PubMed ID: 16968901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ig synthesis and class switching do not require the presence of the hs4 enhancer in the 3' IgH regulatory region.
    Vincent-Fabert C; Truffinet V; Fiancette R; Cogné N; Cogné M; Denizot Y
    J Immunol; 2009 Jun; 182(11):6926-32. PubMed ID: 19454689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immunoglobulin heavy-chain locus hs3b and hs4 3' enhancers are dispensable for VDJ assembly and somatic hypermutation.
    Morvan CL; Pinaud E; Decourt C; Cuvillier A; Cogné M
    Blood; 2003 Aug; 102(4):1421-7. PubMed ID: 12714490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ig heavy chain expression and class switching in vitro from an allele lacking the 3' enhancers DNase I-hypersensitive hs3A and hs1,2.
    Saleque S; Singh M; Birshtein BK
    J Immunol; 1999 Mar; 162(5):2791-803. PubMed ID: 10072526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination.
    Yan Y; Pieretti J; Ju Z; Wei S; Christin JR; Bah F; Birshtein BK; Eckhardt LA
    J Biol Chem; 2011 Aug; 286(31):27123-31. PubMed ID: 21673112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoglobulin heavy chain super enhancer controls class switch recombination in developing B cells.
    Dauba A; Näser E; Andrieux D; Cogné M; Denizot Y; Khamlichi AA
    Sci Rep; 2024 Mar; 14(1):7370. PubMed ID: 38548819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites.
    Garrett FE; Emelyanov AV; Sepulveda MA; Flanagan P; Volpi S; Li F; Loukinov D; Eckhardt LA; Lobanenkov VV; Birshtein BK
    Mol Cell Biol; 2005 Feb; 25(4):1511-25. PubMed ID: 15684400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletional analyses reveal an essential role for the hs3b/hs4 IgH 3' enhancer pair in an Ig-secreting but not an earlier-stage B cell line.
    Shi X; Eckhardt LA
    Int Immunol; 2001 Aug; 13(8):1003-12. PubMed ID: 11470770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 3' end of the heavy chain constant region locus enhances germline transcription and switch recombination of the four gamma genes.
    Dunnick WA; Shi J; Graves KA; Collins JT
    J Exp Med; 2005 May; 201(9):1459-66. PubMed ID: 15851486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cell development arrest upon insertion of a neo gene between JH and Emu: promoter competition results in transcriptional silencing of germline JH and complete VDJ rearrangements.
    Delpy L; Decourt C; Le Bert M; Cogné M
    J Immunol; 2002 Dec; 169(12):6875-82. PubMed ID: 12471120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential activation and distinct functions for distal and proximal modules within the IgH 3' regulatory region.
    Garot A; Marquet M; Saintamand A; Bender S; Le Noir S; Rouaud P; Carrion C; Oruc Z; Bébin AG; Moreau J; Lebrigand K; Denizot Y; Alt FW; Cogné M; Pinaud E
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):1618-23. PubMed ID: 26831080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of aberrant isotype switch recombination in low-grade and high-grade gastric MALT lymphomas.
    Nardini E; Aiello A; Giardini R; Colnaghi MI; Ménard S; Balsari A
    Blood; 2000 Feb; 95(3):1032-8. PubMed ID: 10648419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancers located in heavy chain regulatory region (hs3a, hs1,2, hs3b, and hs4) are dispensable for diversity of VDJ recombination.
    Rouaud P; Vincent-Fabert C; Fiancette R; Cogné M; Pinaud E; Denizot Y
    J Biol Chem; 2012 Mar; 287(11):8356-60. PubMed ID: 22270371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The polymorphism of the locus control region lying downstream the human IgH locus is restricted to hs1,2 but not to hs3 and hs4 enhancers.
    Guglielmi L; Truffinet V; Magnoux E; Cogné M; Denizot Y
    Immunol Lett; 2004 Jun; 94(1-2):77-81. PubMed ID: 15234538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Class switching in B cells lacking 3' immunoglobulin heavy chain enhancers.
    Manis JP; van der Stoep N; Tian M; Ferrini R; Davidson L; Bottaro A; Alt FW
    J Exp Med; 1998 Oct; 188(8):1421-31. PubMed ID: 9782119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3'RR and 5'E
    Ghazzaui N; Issaoui H; Boyer F; Martin OA; Saintamand A; Denizot Y
    Cell Mol Immunol; 2019 Feb; 16(2):198-200. PubMed ID: 30305688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.